Clinical trial · Observational
Bone Metastases Database of Patients Treated Surgically for Impending or Pathologic Fracture of Long Bones
Prospective Bone Metastases Database
NCT03416959CI-TRIAL-00092943BMDrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aims of this study are to collect prospective data on the natural history of bone metastases (BMs) and skeleta related events (SREs),
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neoplasm Metastasis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| intramedullary fixation or endoprosthetic reconstruction | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Clinical outcomes after treatment of long bone metastases with intramedullary nail versus endoprosthetic reconstruction
- timeFrame
- 24 months
- description
- The study includes the collection of clinical data (age, sex, Karnofsky score) and laboratory data related to the patient (erythrocyte sedimentation rate, C reactive protein, Alkaline phosphatase, white blood cells and hemoglobin) at the time of admission, data on the pathology (histotype, site of bone metastasis , presence of further skeletal or visceral metastases), type of surgery performed (stabilization versus resection).The objectives of this study is to examine clinical outcomes after after surgical treatment of bone metastases with a specific focus on differences in complication rate between patients treated with intramedullary nail versus endoprosthetic reconstruction
Secondary outcomes (1)
- measure
- Survival in patients undergoing surgery for metastatic bone disease
- timeFrame
- 24 months
- description
- Provide a reliable and objective means of estimating survival in patients with metastatic bone disease based on disease-specific and laboratory tests
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients with long bone metastases treated surgically with intramedullary nail or endoprosthetic reconstruction Exclusion Criteria: * Patients with bone metastases of the spine
References
Publications (0)
Data not yet available
No reference posted for this study.